NCT02062125Completed
Calcinosis in a Single-Center Scleroderma Population
A Prospective, Observational Study of Calcinosis in a Single-Center Population With Scleroderma-Spectrum Disorders
Source: ClinicalTrials.gov · Last updated 21 Mar 2024
Brief summary (registry, in English)
This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how common and if there are any risk factors for having calcinosis 2\) to identify common complications associated with scleroderma-related calcinosis. .
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 66 (actual)
- First submitted
- 7 Feb 2014
- Start date
- 31 Oct 2012
- Primary completion date
- 15 Mar 2024
- Lead sponsor
- Rutgers, The State University of New Jersey
- Diseases
- Systemic sclerosis (scleroderma)
- NCT number
- NCT02062125
What you commit to
- Study type: Observational
- Participants enrolled: 66
- From 31 Oct 2012 to the primary completion date, 15 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects unwilling to participate
Who the study is looking for
- Adult scleroderma subjects with and without calcinosis
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| RWJ Medical School Coordinator of this site? Confirm its status | New Brunswick | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.